Ainos, Inc.AIMDEarnings & Financial Report
Nasdaq · Health Care · Pharmaceutical Preparations
Ainos, Inc. is a biotechnology firm specializing in the development and commercialization of portable point-of-care diagnostic testing solutions. Its product portfolio includes infectious disease detection kits, hormone testing tools, and general health screening products, serving clinical, consumer, and public health segments across North America, Europe, and the Asia-Pacific.
Insider Transactions
Net 90d: +$511 · buys $511 / sells $0Range:
Action:
Role:
| Insider | Role | Action | ||||
|---|---|---|---|---|---|---|
| 2026-04-30 | chiang yao-chung | Director | Buy (open market) | 200 | $1.68 | $336 |
| 2026-04-29 | chiang yao-chung | Director | Buy (open market) | 100 | $1.75 | $175 |
| 2026-04-15 | lee ting-chuan | Director | Grant | 570.0K | $1.61 | $917.7K |
| 2026-04-15 | TSAI CHUN-JUNG | Director | Grant | 330.0K | $1.61 | $531.3K |
| 2026-04-15 | tsai chun-hsien | CEO, PRESIDENT, CHAIRMAN | Grant | 300.0K | $1.61 | $483.0K |
1–5 of 5